New PLGA-Based Drug Delivery Systems for In V

CD Bioparticles now offers customers a range of PLGA nanoparticles with excellent biocompatibility and biodegradability, including Streptavidin Coated PLGA Nanoparticles, Functionalized PLGA Nanoparticles, and Functionalized Fluorescent Magnetic PLGA Nanoparticles. These monolayer PLGA nanoparticles form nanostructures with a hydrophobic core encapsulated within a hydrophilic shell, and magnetic nanoparticles and dye molecules can be encapsulated within the hydrophobic core. In addition, CD Bioparticles supplies PLGA nanoparticles with various surface modifications, including COOH groups, methoxy-PEG, and PEG-azide, which can be used for EDC/NHS-based bioconjugation, in vivo blood half-life enhancement, and covalent binding of biomolecules, respectively. CD Bioparticles also provides PLGA nanoparticles covalently linked to streptavidin proteins on the surface for a variety of applications, such as dual-labeled fluorescent and magnetic nanoparticles for in vivo targeting. For example, DiagPoly™ Streptavidin Coated Fluorescent Magnetic PLGA Nanoparticles, DiO, 120 nm (Cat.No. CDPLN-01) are labeled with DiO as a fluorescent dye, and form nanostructures with a hydrophobic core wrapped in a hydrophilic shell that can be pulled down by magnetic forces for applications in dual fluorescence, MRI imaging, and delivery of proteins and small molecules. These Streptavidin Coated PLGA Nanoparticles are made from FDA-approved PLGA polymers, and allow for easy loading of antibodies, proteins and small molecules via streptavidin-biotin interaction. CD-Bioparticles' PLGA Nanoparticles are versatile and effective tools for the delivery of therapeutic agents that can be tailored to the specific needs of each application. If you have any further questions or would like to know more about these nanoparticles, please visit the CD Bioparticles website at https://www.cd-bioparticles.com/products/plga-based-drug-delivery-system-for-in-vitro-and-in-vivo-applications.html.